The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.

EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...

Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development ...

An estimated 1% of Multnomah County’s 343,370 homes – or 3,434 households – use wood as their primary heat source ... households that use wood as a secondary heat source or for pleasure ...

Secondary bacterial infections can exacerbate SARS-CoV-2 infection ... for pneumococcal detection (Vector Laboratories, Burlingame, CA). For IHC, a primary monoclonal antibody against SARS-CoV-2 ...

Objectives To evaluate risk factors associated with exacerbation frequency in primary care. Information on exacerbations of chronic obstructive pulmonary disease (COPD) has mainly been generated by ...

The primary outcome was the incidence and severity of the cell therapy-related adverse events (AEs); secondary outcome included other ... The grade III AEs include 2 severe COVID-19 and 2 acute ...

Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...

Conceived in the nineties, it is based upon the concept of decentralization of care, which is now at family level through multidisciplinary Community Health Teams for primary care ... on medication to ...

It does not necessarily reflect the view of The Herald. A NEW data reveals the best primary and secondary schools in Bournemouth, Christchurch and Poole based on their performance. Online ...